Nora Therapeutics Obtains $18,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a5143056-d60d-4886-9290-2b092318ed47
Date
4/17/2014
Company Name
Nora Therapeutics
Mailing Address
530 Lytton Ave. 2nd Floor Palo Alto, CA 94301 USA
Company Description
Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine.
Website
http://www.noratherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$18,000,000
Transaction Round
Series B
Proceeds Purposes
We are further encouraged that enrollment in the THRIVE-IVF trial is ahead of schedule and we have already received significant investigator interest for the upcoming RESPONSE trial.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor